Abstract:Abstract Gliomas are immune cold tumors. Effective therapeutic strategies capable of inducing an immune response are lacking.Here we present evidence that ferroptosis, a form of iron-mediated lipid peroxidation-based cell death, may promote anti-tumor immunity via stimulation of phagocytosis and pro-inflammatory activities in microglia. While ferroptosis has shown promise in induction of glioma cell death, the immunogenic and microenvironmental effects of glioma ferroptosis are poorly understood. First, we tested the in vitro effects of the glutathione peroxidase 4 (GPX4) inhibitor RSL3, a ferroptosis inducer, on murine glioma cell lines. Using flow cytometry, we discovered that RSL3 treatment led to membrane translocation of the pro-phagocytic antigen calreticulin, known hallmark of immunogenic cell death, by an average log2-fold-change of 2.53 (p= 0.03) compared to DMSO-treated controls. This effect correlated with lipid peroxidation, as assessed by BODIPY-C11 staining. To further test the effects of ferroptosis on glioma cell-microglia crosstalk, we prepared acute brain tumor slices from both mouse and human glioma samples, and treated them with RSL3. Quantification of immunofluorescent staining from three independent human slice cultures after RSL3 treatment demonstrated a significant increase in calreticulin abundance as compared to control (p < 0.001). Importantly, this effect was significantly diminished with addition of ferrostatin, an inhibitor of ferroptosis, demonstrating that ferroptosis induction was directly responsible for calreticulin translocation. Single-cell RNAseq on mouse and human acute glioma slice cultures treated with RSL3 demonstrated significant overexpression of calreticulin in the tumor population, and positive enrichment of interferon signaling, antigen presentation, and phagocytosis ontologies in both tumor and myeloid compartments. These findings suggest that ferroptosis-induced translocation of calreticulin on the surface of glioma cells promotes activation of the local immune microenvironment by increasing tumor antigen presentation and pro-inflammatory cytokine release by tumor-associated microglia. Thus, ferroptosis-inducing drugs may promote anti-tumor immunity through the activation of immunogenic cell death signals.

EXTH-11. COLD ATMOSPHERIC PLASMA SELECTIVELY INDUCES APOPTOSIS AND FERROPTOSIS THROUGH REACTIVE OXYGEN SPECIES IN HIGH-GRADE GLIOMA

Surg-58. Cold Atmospheric Plasma (Cap) Causes Selective Tumor Cell Death Via Apoptosis And Ferroptosis In Malignant Glioma Cells

Enhanced Pyrazolopyrimidinones Cytotoxicity Against Glioblastoma Cells Activated by ROS-Generating Cold Atmospheric Plasma.

Cold atmospheric‐pressure plasma selectively inhibits glioblastoma via DNA damage and AKT dephosphorylation in vitro and in vivo

Synergistic Cytotoxicity Between Cold Atmospheric Plasma and Pyrazolopyrimidinones Against Glioblastoma Cells

Capsaicin induces redox imbalance and ferroptosis through ACSL4/GPx4 signaling pathways in U87-MG and U251 glioblastoma cells

Combination of Metformin and Cold Atmospheric Plasma Induces Glioma Cell Death to Associate with C-Fos

CAPG interference induces apoptosis and ferroptosis in colorectal cancer cells through the P53 pathway

Cold Atmospheric Plasma Stimulates Clathrin-Dependent Endocytosis to Repair Oxidised Membrane and Enhance Uptake of Nanomaterial in Glioblastoma Multiforme Cells

Cold plasma irradiation inhibits skin cancer via ferroptosis

Comparative assessment of direct and indirect cold atmospheric plasma effects, based on helium and argon, on human glioblastoma: an in vitro and in vivo study

Induction of glioblastoma cell ferroptosis using combined treatment with chloramphenicol and 2-deoxy-d-glucose

TAMI-57. INDUCTION OF FERROPTOSIS PROMOTES IMMUNOGENIC CELL DEATH AND ACTIVATION OF THE IMMUNE MICROENVIRONMENT IN GLIOMA

Cold atmospheric plasma enhances SLC7A11-mediated ferroptosis in non-small cell lung cancer by regulating PCAF mediated HOXB9 acetylation

Restoration of Sensitivity in Chemo — Resistant Glioma Cells by Cold Atmospheric Plasma

Principles of using Cold Atmospheric Plasma Stimulated Media for Cancer Treatment

Combination therapy of cold atmospheric plasma (CAP) with temozolomide in the treatment of U87MG glioblastoma cells

Cold atmospheric plasmas target breast cancer stemness via modulating AQP3-19Y mediated AQP3-5K and FOXO1 K48-ubiquitination

Trehalose enhanced cold atmospheric plasma-mediated cancer treatment

Cold Atmospheric Plasma Induces Growth Arrest and Apoptosis in Neurofibromatosis Type 1-Associated Peripheral Nerve Sheath Tumor Cells

Cytotoxicity to Melanoma and Proliferation to Fibroblasts of Cold Plasma Treated Solutions with Removal of Hydrogen Peroxide and Superoxide Anion